Orthopaedic surgery in haemophilia patients with inhibitors as the last resort

Haemophilia

Volumn 14, Issue SUPPL. 6, 2008, Pages 56-67

  Rodriguez Merchan, E C ^a,b   Quintana, M ^a   Jimenez yuste, V ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b NONE   (Spain)

Author keywords

Haemophilia; Haemophilic arthropathy; Inhibitors; Orthopaedic surgery; Prevention; Prophylaxis

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9 CONCENTRATE; GOLD 198; NEUTRALIZING ANTIBODY; PARVOVIRUS VECTOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8; RHENIUM 186; YTTRIUM 90;

ANTIBODY PRODUCTION; ARTHROCENTESIS; ARTHRODESIS; ARTHROPATHY; ARTHROPLASTY; BONE CYST; CHEILECTOMY; CONTINUOUS INFUSION; CURETTAGE; DEBRIDEMENT; DRUG DOSE COMPARISON; DRUG MEGADOSE; EVENING DOSAGE; EXPERIMENTAL MODEL; FALSE ANEURYSM; HEMARTHROSIS; HEMOPHILIA; HUMAN; JOINT CONTRACTURE; JOINT DEGENERATION; JOINT SURGERY; LOW DRUG DOSE; MONOTHERAPY; MORNING DOSAGE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOPEDIC SURGERY; OSTEOPHYTE; OSTEOTOMY; PHYSIOTHERAPY; PRIMARY PREVENTION; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; REVIEW; SYNOVECTOMY; SYNOVIORTHESIS; SYNOVITIS; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT INDICATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VIRAL GENE DELIVERY SYSTEM;

ADOLESCENT; ADULT; AGED; ANIMALS; BLOOD COAGULATION FACTOR INHIBITORS; BLOOD COAGULATION FACTORS; BLOOD LOSS, SURGICAL; CHILD; COAGULANTS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EMBOLIZATION, THERAPEUTIC; FACTOR IX; FACTOR VIIA; HEMARTHROSIS; HEMOPHILIA A; HUMANS; INJECTIONS, INTRA-ARTICULAR; MICE; MICE, KNOCKOUT; MIDDLE AGED; ORTHOPEDIC PROCEDURES; QUALITY OF LIFE; RADIOPHARMACEUTICALS; RANGE OF MOTION, ARTICULAR; RECOMBINANT PROTEINS; SYNOVITIS; TIME FACTORS; YOUNG ADULT;

EID: 53249117273     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01891.x     Document Type: Review

References (23)

1. Valentino LA, Hakobyan N, Kazarian T, Jabbar KJ, Jabbar AA. Experimental haemophiic synovitis: Rationale and development of a murine model of human factor VIII deficiency. Haemophilia 2004; 10: 280-7.
2. Roosendaal G, Lafeber FP. Pathogenesis of haemophilic arthropathy. Haemophilia 2006; 12 (Suppl. 3): 117-21.
3. Klamroth R, Essers E, Gottstein S, Wilaschek M, Oldenburg J. Successful angiographic embolization of recurrent elbow joint bleeds in five patient with severe haemophilia A. J Thromb Haemost 2007; 5 (Suppl. 2): P-M-151.
4. Rodriguez-Merchan EC. Methods to treat haemophilic synovitis. Haemophilia 2001; 7: 1-15.
5. Rodriguez-Merchan EC. Therapeutic options in the management of articular contractures in haemophiliacs. Haemophilia 1999; 5 (Suppl. 1): 5-9.
6. Rodriguez-Merchan EC. Orthopaedic surgery of haemophilia in the 21st century: An overview. Haemophilia 2002; 8: 60-8.
7. Sun J, Hakobyan N, Valentino LA, Monahan PE. Local intraarticular expression of factor IX from adeno-associated virus (AAV) vectors prevents development of hemophilic arthropathy. J Thromb Haemost 2007; 5 (Suppl. 2): P-W-233.
8. Valentino LA, Mejia-Carvajal C, Hakobyan N. The impact of joint bleeding and synovitis on physical ability and joint function. J Thromb Haemost 2007; 5 (Suppl. 2): P-W-107.
9. Ovlisen K, Kristensen AT, Tranholm M. Needle induced haemarthrosis: A murine model of hemophilic synovitis. J Thromb Haemost 2007; 5 (Suppl. 2): P-T-153.
10. Sun J, Hakobyan N, Valentino LA, Monahan PE. Factor IX concentrated in the joint space protects hemophilia B mice from bleeding-induced joint deterioration in the absence of circulating factor IX. J Thromb Haemost 2007; 5 (Suppl. 2): O-M-013.
11. Valentino LA, Gruber F, Hakobyan N, Enockson C, Han W. Primary human synovial cells proliferate in response to hemoglobin and whole blood. J Thromb Haemost 2007; 5 (Suppl. 2): P-W-106.
12. Rodriguez-Merchan EC, Quintana M, Jimenez-Yuste V, Hernandez-Navarro F. Orthopaedic surgery for inhibitor patients: A series of 27 procedures (26 patients). Haemophilia 2007; 13: 613-19.
13. Solimeno LP, Perfetto OS, Pasta G, Santagostino E. Total joint replacement in patients with inhibitors. Haemophilia 2006; 12 (Suppl. 3): 113-16.
14. Marquès-Verdier A, Chaleteix C, Soulié B, Bay JO. Secondary prophylaxis with recombinant activated factor VII (rFVIIa) in a severe haemophilia A patient with anti-factor VIII inhibitors. J Thromb Haemost 2007; 5 (Suppl. 2): P-T-168.
15. Donfield SM, Lail AE, Gomperts ED, Hoots W, Berntorp E, Lynn HS. Association between a history of inhibitors and delays in skeletal maturation in adolescent with hemophilia. J Thromb Haemost 2007; 5 (Suppl. 2): O-S-066.
16. Rodriguez-Merchan EC, de la Corte-Rodriguez H, Romero-Garrido JA et al. Radiosynoviorthesis is necessary in hemophilic patients despite prophylaxis. J Thromb Haemost 2007; 5 (Suppl. 2): P-W-126.
17. Rodriguez-Merchan EC, Quintana-Molina M, Jiménez-Yuste V, de la Corte-Rodriguez H, Hernández-Navarro F. Surgery in hemophilia patients with inhibitors: Report of 91 surgical procedures. J Thromb Haemost 2007; 5 (Suppl. 2): P-W-127.
18. Laurian YD, Tagariello G, Jimenez Yuste V et al. Primary knee arthroplasty using recombinant factor VIIa (rFVIIa) as first-line therapy in haemophilia patients with high responding inhibitors. J Thromb Haemost 2007; 5 (Suppl. 2): P-M-140.
19. Kreuz W, Escuriola-Ettinghausen C, Martinez I et al. Effective and safe long-term prophylaxis in patients with high-titer inhibitors using factor VIII inhibitor bypass activity (FEIBA). Thromb Haemost 2001; July Suppl: Abstract P2542.
20. Centra M, Mancuso G, Morfini M et al. APCC (FEIBA) home treatment prophylaxis: An opportunity for inhibitor hemophilia A patients. Thromb Haemost 2001; July Suppl: Abstract P2546.
21. Saxon BR, Jory CB. Effective prophylaxis with daily rFVIIa (NovoSeven) in a child with high titer inhibitors and a target joint. Haemophilia 2000; 6: 299.
22. Rodriguez-Merchan EC. Some recent developments regarding arthropathy and inhibitors in haemophilia. Haemophilia 2008; 14: 242-7.
23. Obergfell A, Auvinen MK, Mathew P. Recombinant activated factor VII for haemophilic patients with inhibitors undergoing orthopaedic surgery: A review of the literature. Haemophilia 2008; 14: 233-41.